WinstonWınston
Back
Stock

The Cooper Companies

COO
47
Medical - Instruments & Supplies · Healthcare
Also trades as: 0I3I.L GBP 0.55 (-2.41%)
Price
$54.75
-1.68 (-2.98%)
Market Cap
$10.68B
Exchange
NASDAQ
Winston Score
47
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Oct 8, 2026 · filings through Jul 31, 2026

§How the score breaks down

Quality
Good
18/30
Growth
Good
10/20
Cash Flow
Weak
1/10
Stability
Strong
7/10
Valuation
Strong
8/10
Ownership
Weak
2/15
Dividends
Weak
1/5

47 of 100 counted points = Winston Score 47.

Track this stock — start free trial

§Winston Score History

The full picture

The Cooper Companies makes medical products sold mainly to eye doctors and women's health clinics. Its biggest division, CooperVision, makes contact lenses — including popular daily and specialty lenses — and competes with giants like Johnson & Johnson and Alcon. Its other division, CooperSurgical, makes devices and fertility-related products used by OB-GYNs and fertility clinics.

The company earns money by selling its products directly to eye care professionals and medical providers, mostly on a recurring basis since contact lens wearers need fresh lenses regularly. Cooper operates globally, with significant revenue from the Americas, Europe, and Asia-Pacific, and generated roughly $4 billion in annual revenue in recent fiscal periods. Its moat comes from strong customer relationships and a broad specialty lens portfolio, but the company carries a heavy debt load from past acquisitions — particularly CooperSurgical — which keeps its return on invested capital low and limits financial flexibility if growth slows.

Politician Trades

9 trades / 12mo

4 Congressional buys and 5 sells on COO in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+0.6% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+357.1% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$172M/ year

↑ Rising (+11% vs prior year)

4.2% of revenue

Below sector average (18%)

R&D investment increasing — building for the future

Insider Activity

0.7%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~1 months

$155M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

The Cooper Companies has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

+0.3% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 199.4M (2021) → 200.0M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
66.8%
Premium pricing power — 66.8% gross margin
Profit after running costs
Operating Margin
20.8%
Excellent — 20.8% operating margin
Return on the money invested
ROCE
5.0%
Weak — 5.0% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+4.7%
Slow sales growth (+4.7% YoY)
Profit growth
EPS YoY
+43.6%
Earnings growing fast (+43.6% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
32%
Weak — only 32% of profit becomes cash
Spare cash per sale
FCF Margin
-7.1%
Burning cash (-7.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.31
Conservative — low debt load (0.31)
Covers its interest
Interest Cover
6.10x
Adequate interest coverage (6.1x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
18.7x
Fair value — P/E 18.7

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+7.5
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (18.7 → 11.1)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.11%
Small dividend — 0.11% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial